CanSino Biologics Inc. (CASBF)
OTCMKTS · Delayed Price · Currency is USD
3.200
-1.400 (-30.43%)
At close: Apr 9, 2025

CanSino Biologics Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Cash & Equivalents
1,5212,0232,8223,4655,6454,447
Upgrade
Short-Term Investments
----275.2-
Upgrade
Trading Asset Securities
1,5671,1821,3082,4821,862666.64
Upgrade
Cash & Short-Term Investments
3,0883,2044,1305,9477,7835,114
Upgrade
Cash Growth
-23.08%-22.41%-30.55%-23.59%52.19%577.49%
Upgrade
Accounts Receivable
665.93737.62636.88855.49157.9322.14
Upgrade
Other Receivables
11.5681.113.980.5419.150.25
Upgrade
Receivables
677.49818.73640.87856.03177.0822.4
Upgrade
Inventory
322.56283.41352.85677.78875.62170.51
Upgrade
Prepaid Expenses
--0.25---
Upgrade
Other Current Assets
45.97-24.0357249.59454.49114.07
Upgrade
Total Current Assets
4,1344,2825,1817,7309,2905,421
Upgrade
Property, Plant & Equipment
2,6362,6413,0133,0692,218873.95
Upgrade
Long-Term Investments
16.22483.71446.5650.1245.31265.44
Upgrade
Other Intangible Assets
112.21115.49144.15220.92172.1236.9
Upgrade
Long-Term Deferred Tax Assets
210.57205.39207.86196.41--
Upgrade
Long-Term Deferred Charges
172.32172.2188.451.9526.1943.37
Upgrade
Other Long-Term Assets
538.5857.99237.53150.37122.42107.78
Upgrade
Total Assets
7,8207,9589,31911,46911,8746,748
Upgrade
Accounts Payable
56.7562.47103.97253.12842.5760.57
Upgrade
Accrued Expenses
136.68401.46454.55407.25362.44157.82
Upgrade
Short-Term Debt
213.62377.35883.971,530990.68-
Upgrade
Current Portion of Long-Term Debt
-513.44509.1745.7790.1140.16
Upgrade
Current Portion of Leases
-9.9964.6348.7631.188.59
Upgrade
Current Income Taxes Payable
-4.660.54329.14-
Upgrade
Current Unearned Revenue
37.8914.693.571.48193.220.42
Upgrade
Other Current Liabilities
1,115302.68544.9635.52322.08141.91
Upgrade
Total Current Liabilities
1,5601,6872,5652,9252,861409.47
Upgrade
Long-Term Debt
1,1151,0991,066878.014090
Upgrade
Long-Term Leases
11.1112.68175.18198.29222.853.79
Upgrade
Long-Term Unearned Revenue
236.01250.3216.72222.35201.48173.96
Upgrade
Long-Term Deferred Tax Liabilities
----0.56-
Upgrade
Other Long-Term Liabilities
--8.49---
Upgrade
Total Liabilities
2,9223,0484,0314,2233,326677.22
Upgrade
Common Stock
247.45247.45247.45247.45247.45247.45
Upgrade
Additional Paid-In Capital
6,5776,5776,5746,6086,5986,588
Upgrade
Retained Earnings
-1,830-1,819-1,44042.711,150-764.69
Upgrade
Treasury Stock
-95.62-95.62-106.17-150.17--
Upgrade
Comprehensive Income & Other
0.220.22-0.180.12--
Upgrade
Total Common Equity
4,8994,9105,2756,7487,9956,071
Upgrade
Minority Interest
--12.81497.51552.84-
Upgrade
Shareholders' Equity
4,8994,9105,2877,2468,5486,071
Upgrade
Total Liabilities & Equity
7,8207,9589,31911,46911,8746,748
Upgrade
Total Debt
1,3402,0122,6992,7011,375142.54
Upgrade
Net Cash (Debt)
1,7491,1921,4313,2466,4084,971
Upgrade
Net Cash Growth
11.03%-16.69%-55.91%-49.34%28.90%745.44%
Upgrade
Net Cash Per Share
7.174.825.8013.1425.9121.56
Upgrade
Filing Date Shares Outstanding
230.91249.18247.04246.77247.45247.45
Upgrade
Total Common Shares Outstanding
230.91249.18247.04246.77247.45247.45
Upgrade
Working Capital
2,5752,5962,6164,8056,4285,011
Upgrade
Book Value Per Share
21.2219.7021.3527.3532.3124.53
Upgrade
Tangible Book Value
4,7874,7945,1306,5277,8236,034
Upgrade
Tangible Book Value Per Share
20.7319.2420.7726.4531.6124.38
Upgrade
Buildings
-1,025978.89729.03724.6837.19
Upgrade
Machinery
-773.611,1891,050537.75120.73
Upgrade
Construction In Progress
-1,2681,1141,342820.8760.05
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.